GeneOne Life Science and Inovio Pharmaceuticals to Collaborate on Zika Virus Vaccine Development
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Maxim Positive on Inovio Pharma's (INO) Zika Virus Vaccine Collaboration; Reaffirms at 'Buy'
January 22, 2016 10:03 AM ESTMaxim affirms Inovio Pharmaceuticals (Nasdaq INO) with a Buy rating and $14 price target after the company announced a new collaboration with GeneOne... More
Inovio Pharma (INO) Goins Amid New Zika Virus Vaccine Collaboration
January 22, 2016 9:41 AM ESTInovio Pharmaceuticals (Nasdaq: INO) shares are up early after it and GeneOne Life Science entered a... More
